VDR and Hepatic fibrosis: In HSCs, VDR activation has been reported to potently repress TGFβ-induced profibrotic gene expression by antagonizing SMAD-dependent transcriptional programs, suggesting that targeting VDR with less calcemic ligands might be beneficial for the prevention and treatment of liver fibrosis [82].